Cargando…

Hepatocellular carcinoma in elderly patients: challenges and solutions

Hepatocellular carcinoma (HCC) is the second most common cause of death by cancer in the world. Due to the delayed HCC development in hepatitis C carriers and nonalcoholic fatty liver disease, the incidence of HCC in the elderly is increasing and is becoming a global health issue. Elderly patients w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunot, Angélique, Le Sourd, Samuel, Pracht, Marc, Edeline, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4994800/ https://www.ncbi.nlm.nih.gov/pubmed/27574587 http://dx.doi.org/10.2147/JHC.S101448

Ejemplares similares

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma
por: Lescure, Céline, et al.
Publicado: (2021)

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
por: Palard, Xavier, et al.
Publicado: (2017)

Patients’ Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life
por: Muzellec, Léa, et al.
Publicado: (2021)

Pediatric hepatocellular carcinoma: challenges and solutions
por: Schmid, Irene, et al.
Publicado: (2017)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

Current Evidence for Immune Checkpoint Inhibition in Advanced Hepatocellular Carcinoma
por: Foy, Victoria, et al.
Publicado: (2023)

Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas
por: Goislard de Monsabert, Camille, et al.
Publicado: (2021)

Optimal therapy for patients with hepatocellular carcinoma and resistance or intolerance to sorafenib: challenges and solutions
por: Ray, Emily M, et al.
Publicado: (2017)

Hyponatremia in the elderly: challenges and solutions
por: Filippatos, Theodosios D, et al.
Publicado: (2017)

Bladder cancer in the elderly patient: challenges and solutions
por: Guancial, Elizabeth A, et al.
Publicado: (2015)

Emergency surgery in the elderly: challenges and solutions
por: Torrance, Andrew D W, et al.
Publicado: (2015)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
por: Pracht, M., et al.
Publicado: (2013)

Multiple myeloma in the very elderly patient: challenges and solutions
por: Willan, John, et al.
Publicado: (2016)

CAR-T cells and BiTEs in solid tumors: challenges and perspectives
por: Edeline, Julien, et al.
Publicado: (2021)

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

How to assess the efficacy or failure of targeted therapy: Deciding when to stop sorafenib in hepatocellular carcinoma
por: Raoul, Jean-Luc, et al.
Publicado: (2016)

Managing atrial fibrillation in the very elderly patient: challenges and solutions
por: Karamichalakis, Nikolaos, et al.
Publicado: (2015)

Challenges and Solutions in the Management of Hepatocellular Carcinoma Associated with Non-Alcoholic Fatty Liver Disease
por: Cadar, Ramona, et al.
Publicado: (2023)

How to Treat Hepatocellular Carcinoma in Elderly Patients
por: Federico, Piera, et al.
Publicado: (2021)

Challenges of advanced hepatocellular carcinoma
por: Colagrande, Stefano, et al.
Publicado: (2016)

New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations
por: Edeline, Julien, et al.
Publicado: (2022)

Metastatic castration-resistant prostate cancer in very elderly patients: challenges and solutions
por: Caffo, Orazio, et al.
Publicado: (2016)

Managing Chronic Rhinosinusitis with Nasal Polyps in the Elderly: Challenges and Solutions
por: Merrill, Tyler, et al.
Publicado: (2022)

Boosted selective internal radiation therapy with (90)Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
por: Garin, E., et al.
Publicado: (2013)

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
por: Lenoir, Laurence, et al.
Publicado: (2012)

Treatment for Hepatocellular Carcinoma in Elderly Patients: A Literature Review
por: Nishikawa, Hiroki, et al.
Publicado: (2013)

Hepatocellular carcinoma in the elderly
por: Uzzau, Alessandro, et al.
Publicado: (2009)

Challenge and Hope in Radiotherapy of Hepatocellular Carcinoma
por: Seong, Jinsil
Publicado: (2009)

Hepatocellular carcinoma: early-stage management challenges
por: Erstad, Derek J, et al.
Publicado: (2017)

Intratumor Heterogeneity in Hepatocellular Carcinoma: Challenges and Opportunities
por: Kalasekar, Sharanya Maanasi, et al.
Publicado: (2021)

NAFLD‐related hepatocellular carcinoma: The growing challenge
por: Shah, Pir Ahmad, et al.
Publicado: (2023)

Safety and Efficacy of Transarterial Chemoembolization in Elderly Patients with Intermediate Hepatocellular Carcinoma
por: Roth, Gael S., et al.
Publicado: (2022)

The efficacy of treatment for hepatocellular carcinoma in elderly patients
por: Lee, Han Ah, et al.
Publicado: (2023)

Hepatocellular carcinoma in patients with renal dysfunction: Pathophysiology, prognosis, and treatment challenges
por: Yeh, Hsuan, et al.
Publicado: (2021)

Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2022)

Herbal Medicine and Hepatocellular Carcinoma: Applications and Challenges
por: Li, Yan, et al.
Publicado: (2011)

Hepatocellular Carcinoma in Asia: A Challenging Situation
por: Jafri, Wasim, et al.
Publicado: (2019)

Circulating tumor DNA in hepatocellular carcinoma: trends and challenges
por: Tang, Jia-Cheng, et al.
Publicado: (2016)

Immunotherapy of hepatocellular carcinoma: Unique challenges and clinical opportunities
por: Pardee, Angela D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_npjv9rialt7mjqsdsfoq1bruh3